ARCHIMED

Agatha Inc. is a software solution provider focused on the healthcare and life sciences sectors, offering a cloud-based content management platform tailored for hospitals, pharmaceutical companies, and clinical research organizations. Founded in 2015 and headquartered in Tokyo, Japan, Agatha's platform facilitates the management of various quality and clinical documentation processes, including deviations, corrective and preventive actions (CAPA), complaints, audits, and change control. It also streamlines the authoring, review, and distribution of standard operating procedures (SOPs) and manages regulatory documentation in accordance with established models. With features such as immediate availability, e-training, compliance support, and private cloud services, Agatha aims to optimize the workflow and quality management in clinical research and trials for its clients.

Irrimax Corporation specializes in the development, clinical research, manufacturing, and commercialization of medical technologies aimed at treating and preventing infections. Founded in 2003 and based in Lawrenceville, Georgia, the company offers Irrisept, a wound debridement and cleansing system designed to effectively remove bacteria, particulate matter, and debris from wounds while preserving underlying tissues. Irrimax's products are distributed through various suppliers and distributors across the United States. The company is committed to improving patient outcomes, enhancing the safety of healthcare professionals, and reducing healthcare costs. Irrimax operates as a subsidiary of Innovation Technologies, Inc.

Title21 Health Solutions is a user-centric and innovative technology that provides fully-integrated and flexible solutions to health science organizations to increase operational efficiency, close compliance gaps, and improve patient care and outcomes. Since 2001, Title21 has created adaptable software products targeted to the unique needs of firms in the regulated life science industry. The flexible and user-friendly technology that made Title21 the go-to quality management platform and is now available to fully-automate cellular therapy environments.

Corealis Pharma is a contract service provider specializing in formulation and process development for pharmaceutical and biotech companies. The company focuses on the manufacturing of small-scale clinical trial materials and the packaging of solid dosage forms, including tablets, capsules, and granules. Corealis Pharma offers a comprehensive range of services, including active pharmaceutical ingredient (API) characterization, salt selection, pre-formulation, and analytical method development. Additionally, the company provides stability storage and testing, technical transfer, scale-up, cGMP manufacturing, and packaging for phase I and II clinical trial materials, along with dossier support. By aligning its efforts with client needs, Corealis Pharma ensures that the development of drugs meets industry standards and requirements.

CARSO Group specializes in environmental and agrifood analytical services, focusing on the analysis of pollutants such as dioxins through high-resolution mass spectrometry. Established in 1992 by Neptune Technologies and the CNRS, the company expanded its expertise by acquiring water and asbestos analysis operations from the Institut Pasteur in Lyon in 1997. Throughout the 2000s, CARSO enhanced its analytical capabilities through strategic acquisitions of laboratories, including those specializing in radioactivity and bioassays. One notable method employed by CARSO involves the use of non-invasive pollutant shrimp, known as gammarids, to assess chemical contamination and toxicity in freshwater and wastewater environments. This comprehensive approach enables CARSO to offer a diverse array of analytical and associated services to its clients.

Cardioline is a design and the manufacturing of highly performing medical located in Milan.

Cube Biotech specializes in innovative products and solutions for membrane protein research, which is critical for pharmaceutical development. The company operates on a dual business model that includes a service unit focused on structural analysis of membrane proteins and a product unit that generates consistent revenue. Membrane proteins are essential for understanding various diseases and are key targets in drug discovery. However, analyzing these proteins presents significant challenges, especially for human membrane proteins such as transporters and G-protein coupled receptors. Cube Biotech addresses this need with a comprehensive portfolio that includes nanodiscs, purification resins, magnetic beads, and ultrapure detergents, all designed to facilitate access to crucial membrane protein structural information. The company's competitive edge lies in its ability to deliver value across the entire membrane protein research spectrum using its unique technology. With a team that has over 40 years of collective experience in membrane protein expression, purification, and crystallization, Cube Biotech provides valuable opportunities for researchers in both the pharmaceutical and biotechnological sectors as well as academia.

Xpress Biologics is a company providing a large range of services from the design of expression systems to pre-clinical productions. As a One-Stop-Shop, Xpress Biologics can also ensure the management of clinical trials.

Stragen is a global player in the development, registration, and distribution of Generic drugs, Consumer Health products, and Original drugs.

Ad-Tech Medical Instrument Corporation is a leading manufacturer and distributor of intra-cranial monitoring devices, particularly electrodes used in the treatment of intractable epilepsy and related neurosurgical instrumentation. The company's products are designed for long-term EEG monitoring, mapping, SEEG, and brain stimulation for individuals with epilepsy and other neurological disorders. Ad-Tech offers a range of proprietary electrode designs, including subdural strip and grid electrodes, depth electrodes, and cranial nerve electrodes, along with accessory placement devices and brain biopsy needles. These devices are characterized by advanced materials, ease of use, and innovative connection systems, ensuring high safety and effectiveness in clinical applications. With over 30 years of experience, Ad-Tech has established a reputation for quality-driven manufacturing and innovative designs, including pioneering tunneling techniques to reduce the risk of cerebrospinal fluid leakage. The company's depth electrode design is widely regarded as the gold standard in the industry. Continuous innovation has allowed Ad-Tech to expand its product offerings and maintain a strong position in the neuro-monitoring and neurosurgery markets.

ActiGraph is a provider of digital health technology solutions focused on objective measurement of physical activity and sleep. The company offers medical-grade wearable devices that capture continuous digital metrics related to activity, sleep, and mobility, which are utilized in various clinical studies and research initiatives. ActiGraph aims to enhance global health by delivering accurate and scientifically validated monitoring solutions tailored for research, pharmaceutical, healthcare, and wellness organizations. With a commitment to innovation and cost-effectiveness, the company collaborates closely with clients to identify trends and adapt to the evolving landscape of the industry. This enables ActiGraph to offer comprehensive hardware, software, and data management solutions that support research and clinical data collection, analysis, and management. Headquartered in Pensacola, Florida, ActiGraph is dedicated to facilitating the collection of real-time data in clinical trials, thereby contributing to advancements in understanding physical activity, energy expenditure, and sleep behaviors.

EuroLyser Diagnostica GmbH, based in Salzburg, Austria, specializes in the development, manufacturing, and distribution of medical and veterinary diagnostic products. The company focuses on point-of-care testing devices and kits, aiming to enhance the speed and accuracy of medical diagnostics. By providing instruments and test kits designed for use in doctors' practices and hospital emergency rooms, EuroLyser enables physicians to make quicker decisions, independent of laboratory results. This approach not only streamlines the diagnostic process but also facilitates timely treatment, which is essential for effective healthcare management.

Diesse is an Italian developer of innovative in vitro diagnostic (‘IVD’) systems for the diagnosis of infectious and autoimmune diseases.

Soest Medical Group, based in Soest, the Netherlands, specializes in the development and manufacturing of self-adhesive medical supplies, primarily used to secure protective drapes to patients' skin during surgical procedures. Founded in 1990, the company works closely with hospitals and universities to research and improve its product offerings. Soest Medical Group provides both reusable and disposable options, allowing clients to select from a diverse range of products tailored to meet the needs of medical care institutions. The company prioritizes customer connection and collaboration in optimizing its standard and customized solutions.

Fytexia is a supplier of innovative, natural ingredients aimed at the international food supplement industry. Based in the South of France, the company specializes in providing scientifically proven solutions that deliver health benefits inspired by the Mediterranean diet. Its product offerings include diet polyphenols, antioxidants, nutraceuticals, and sports nutrition. By focusing on natural ingredients, Fytexia helps clients mitigate risk factors associated with non-communicable diseases through effective nutritional supplements.

Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.

Micromed is an Italian company that specializes in the manufacturing of medical devices designed for neurophysiology diagnostics. The company produces a comprehensive range of electro medical devices that monitor the electrical activity of the brain, muscles, and nerves. Their product lineup includes systems for long-term monitoring (LTM), intensive care unit (ICU) applications, electroencephalograms (EEG), electromyograms (EMG), and polysomnography (PSG). This extensive offering allows clients to access a variety of electromedical devices tailored for neurology diagnostics.

Herb's International Service is a French leader in natural health ingredients. A team of 25 people who are passionate with botanicals. An agile company expert in sourcing herbal raw material. Sourcing means genuine quality, traceability, environment and ethical practices. We are audited each year by Ecocert and we have been granted the excellence label as a responsible company. We believe in partnership and work closely with our farmers, contract manufacturers to deliver the best ingredients to our customers. We design many type of natural ingredients using our raw material and we share our expertise with you. Service is key for us. We are dedicated to your projects.

Deallus is a global life sciences management consultancy that provides strategic intelligence consulting services specifically tailored for the life sciences sector. The company offers comprehensive advisory services covering various aspects, including product introduction and sustaining corporate innovation. By equipping clients with the necessary insights and strategies, Deallus enables them to make informed decisions and secure competitive advantages in a challenging marketplace.

Centri Dentistici Primo operates a network of dental clinics throughout Italy, providing a comprehensive range of dental services. Their offerings include dental hygiene, conservation, implantology, prosthetics, orthodontics, endodontics, and periodontology, ensuring that patients of all ages receive personalized care and specific treatments. The company emphasizes the importance of trust and transparency in its patient relationships, fostering clear and sincere communication. This approach is aimed at creating a reliable and supportive environment for individuals seeking dental care.

Centri Dentistici Primo operates a network of dental clinics throughout Italy, providing a comprehensive range of dental services. Their offerings include dental hygiene, conservation, implantology, prosthetics, orthodontics, endodontics, and periodontology, ensuring that patients of all ages receive personalized care and specific treatments. The company emphasizes the importance of trust and transparency in its patient relationships, fostering clear and sincere communication. This approach is aimed at creating a reliable and supportive environment for individuals seeking dental care.

Citieffe s.r.l., established in 1962 and headquartered in Calderara di Reno, Italy, specializes in the design and manufacture of surgical instruments. The company is recognized for developing innovative and patented medical products, including intramedullary nails designed for trochanter fractures and advanced external fixation devices focused on reconstruction. Through its commitment to quality and innovation, Citieffe s.r.l. plays a significant role in the healthcare sector, providing essential tools that enhance surgical procedures.